Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Algeum-D is a combination supplement containing calcium carbonate (derived from algae or coral sources) and vitamin D3 (cholecalciferol). It is used to prevent and treat calcium and vitamin D3 deficiencies, and to support bone health in conditions such as osteoporosis, osteomalacia, rickets, tetany, and hypoparathyroidism. Calcium is an essential mineral required for bone formation and maintenance, while vitamin D3 enhances the absorption of calcium from the gastrointestinal tract and stimulates bone mineralization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium carbonate + cholecalciferol (Radiant Pharmaceuticals).